Fibrous Dysplasia, McCune-Albright Syndrome Patient Registry
Launched by TOVAH BURSTEIN · Jul 24, 2017
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
The Fibrous Dysplasia and McCune-Albright Syndrome (FD/MAS) Patient Registry is a research study designed to gather important information from patients and their families about living with these conditions. By completing simple questionnaires, participants can help researchers understand the challenges and experiences associated with fibrous dysplasia, McCune-Albright syndrome, and Mazabraud syndrome. This study is currently recruiting individuals of all ages and genders who have been clinically diagnosed with any of these conditions.
If you or a family member are eligible, you can join the registry and share your story to support valuable research. Participants can expect to fill out surveys that help shed light on their daily lives and health experiences. This information is crucial for improving care and treatment options in the future. To learn more, enroll, or complete your surveys, visit www.fdmasregistry.org. Your participation can make a difference!
Gender
ALL
Eligibility criteria
- Inclusion Criteria any one or more of the following:
- • clinical diagnosis of fibrous dysplasia
- • clinical diagnosis of McCune-Albright syndrome
- • clinical diagnosis of Mazabraud's syndrome
About Tovah Burstein
Tovah Burstein is a distinguished clinical trial sponsor dedicated to advancing innovative therapies in oncology. With a strong focus on precision medicine, the organization conducts rigorous research aimed at improving treatment outcomes for patients with cancer. Tovah Burstein collaborates with leading academic institutions and healthcare providers to design and implement clinical trials that adhere to the highest standards of scientific integrity and ethical practice. Committed to patient safety and the pursuit of groundbreaking discoveries, Tovah Burstein plays a pivotal role in transforming cancer care through its comprehensive approach to clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Grandville, Michigan, United States
Bethesda, Maryland, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials